Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene- induced mammary tumors: Association between lactoperoxidase and estrogen-adduct production

Endocrine-Related Cancer

Volumn 18, Issue 4, 2011, Pages 529-539

  Soriano, Ofelia ^a   Delgado, Guadalupe ^a   Anguiano, Brenda ^a   Petrosyan, Pavel ^b   Molina Servín, Edith D ^b   Gonsebatt, Maria E ^b   Aceves, Carmen ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOPHILIN; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; LACTOPEROXIDASE; LIOTHYRONINE; PENDRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM IODIDE; THIAMAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST; BREAST TUMOR; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA ISOLATION; FEMALE; MAMMARY GLAND; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENS; CASPASE 3; DNA ADDUCTS; DNA DAMAGE; ESTROGENS; FEMALE; IODINE; LACTOPEROXIDASE; MAMMARY NEOPLASMS, EXPERIMENTAL; POTASSIUM IODIDE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND;

EID: 80051765578     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0065     Document Type: Article

References (45)

1. Aceves C & Anguiano B 2009 Is iodine an antioxidant and antiproliferative agent for the mammary and prostate glands?. In Comprehensive Handbook of Iodine. Nutritional, Endocrine and Pathological Aspects, pp 249-257. Eds VR Preedy, GN Burrow &RR Watson. Oxford, England: Academic Press.
2. Aceves C, García-Solís P, Arroyo-Helguera O, Vega-Riveroll L, Delgado G & Anguiano B 2009 Antineoplastic effect of iodine in mammary cancer. Participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR). Molecular Cancer 8 33-36. (doi:10.1186/1476-4598-8-33)
3. Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R & Belfiore A 2006 Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology 47 4463-4475. (doi:10.1210/en.2005-1610)
4. Al-Dhaheri WS, Hassouna I, Al-Salam S & Karam SM 2008 Characterization of breast cancer progression in the rat. Annals of the New York Academy of Sciences 1138 121-131. (doi:10.1196/annals.1414.018)
5. Alva-Sanchez C, Sánchez-Huerta K, Arroyo-Helguera O, Anguiano B, Aceves C & Pacheco-Rosado J 2009 The maintenance of hippocampal pyramidal neuron populations is dependent on the modulation of specific cell cycle regulators by thyroid hormones. Brain Research 1271 27-35. (doi:10.1016/j. brainres.2009.02.043)
6. Anderson WA, Perotti ME, McManaway M, Lindsey S &Eckberg WR 1984 Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes. Journal of Submicroscopic Cytology 16 673-690.
7. Anguiano B, García-Solís P, Delgado G & Aceves C 2007 Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: evidence that chronic administration has no harmful effects. Thyroid 17 851-859. (doi:10.1089/thy.2007.0122)
8. Arroyo-Helguera O, Anguiano B, Delgado G & Aceves C 2006 Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocrine-Related Cancer 13 1147-1158. (doi:10.1677/erc.1.01250)
9. Arroyo-Helguera O, Rojas E, Delgado G & Aceves C 2008 Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects. Endocrine-Related Cancer 15 1003-1011. (doi:10.1677/ERC-08-0125)
10. Burgui H, Schaffner TH & Seller JP 2001 The toxicology of iodate: a review of the literature. Thyroid 11 449-456. (doi:10.1089/105072501300176408)
11. Cavalieri EL & Rogan EG 2010 Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncology 6 7-10. (doi:10.2217/fon.09.137)
12. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK et al. 1997 Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumour initiators. PNAS 94 10937-10942. (doi:10.1073/pnas.94.20.10937)
13. Davies MJ, Hawkins CL, Pattison DI & Rees MD 2008 Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxidants & Redox Signaling 10 1199-1234. (doi:10.1089/ars.2007.1927)
14. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS & Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews 24 48-77. (doi:10.1210/er.2001-0029)
15. Dugrillon A, Uedelhoven W, Pisarev M, Bechtner G &Gartner R 1994 Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles. Hormone and Metabolic Research 26 465-469. (doi:10.1055/s-2007-1001734)
16. Funahashi H, Imai T, Tanaka Y, Tobinaga J, Wada M, Morita T, Yamada F, Tsukamura K, Oiwa M, Kikumori T et al. 1996 Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. Journal of Surgical Oncology 61 209-213. (doi:10.1002/(SICI)1096-9098(199603)61:3〈209::AID-JSO9〉3.0. CO;2-F)
17. 2prevents cancer promotion. Molecular and Cellular Endocrinology 236 49-57. (doi:10.1016/j.mce.2005.03.001)
18. Ghent W, Eskin B, Low D & Hill L 1993 Iodine replacement in fibrocystic disease of the breast. Canadian Journal of Surgery 36 453-460. (Pubitemid 23357300)
19. Guo Q, Detweiler CD & Mason RP 2004 Protein radical formation during lactoperoxidase-mediated oxidation of the suicide substrate glutathione. Immunochemical detection of a lactoperoxidase radical-derived 5,5-dimethyl-1-pyrroline n-oxide nitrone adduct. Journal of Biological Chemistry 279 13272-13283. (doi:10.1074/jbc.M310034200)
20. Kenkel J 1994 Analytical Chemistry for Technicians, 2nd edition. Boca Raton, FL, USA: CRC Press.
21. Kessler JH 2004 The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Breast Journal 10 328-336. (doi:10.1111/j.1075- 122X.2004.21341.x)
22. Kussendrager KD & van Hooijdonk AC 2000 Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. British Journal of Nutrition 84 (Supplement 1) S19-S25. (Pubitemid 32106826)
23. Lareef MH, Garber J, Russo PA, Russo IH, Heulings R & Russo J 2005 The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. International Journal of Oncology 26 423-429.
24. Liu XH, Chen GG, Vlantis AC, Tse GM & Van Hasselt CA 2010 Iodine induces apoptosis via regulating MAPKs-related p53, p21, and Bcl-xL in thyroid cancer cells. Molecular and Cellular Endocrinology 320 128-135. (doi:10.1016/j.mce.2010.02.004)
25. Lovstad RA 2006 A kinetic study on the lactoperoxidase catalyzed oxidation of estrogens. Biometals: an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine 19 587-592. (doi:10.1007/s10534- 006-0002-3)
26. Memphan TB 1987 Physiology of Lactation. Philadelphia, PA, USA: Open University Press.
27. Nandi S, Guzman RC & Yang J 1995 Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. PNAS 92 3650-3657. (doi:10.1073/pnas.92.9.3650)
28. Nuñez-Anita RE, Arroyo-Helguera O, Cajero-Juárez M, López-Bojorquez L & Aceves C 2009 A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer. Prostaglandins & Other Lipid Mediators 89 34-42. (doi:10.1016/j.prostaglandins.2009.04.001)
29. Park JW, Zarnegar R, Kanauchi H, Wong MG, Hyun WC, Ginzinger DG, Lobo M, Cotter P, Duh QY & Clark OH 2005 Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. Thyroid 15 222-231. (doi:10.1089/thy.2005.15.222)
30. Paul T, Meyers B, Witorch RJ, Pino S, Chipkin S, Ingbar SH & Braverman LE 1988 The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism 37 121-124. (doi:10.1016/S0026- 0495(98)90004-X)
31. Phillips DH & Arlt VM 2007 The 32P-postlabeling assay for DNA adducts. Nature Protocols 2 2772-2781. (doi:10.1038/nprot.2007.394)
32. Pisarev M, Krawiec L, Juvenal G, Bocanera L, Pregliasco L, Sartorio G & Chester H 1994 Studies on the goiter inhibiting action of iodolactones. European Journal of Pharmacology 258 33-37. (doi:10.1016/0014-2999(94)90054-X)
33. Rillema J & Mulder J 1978 Arachidonic acid distribution in lipids of mammary glands and DMBA-induced tumors of rats. Prostaglandins and Medicine 1 31-38. (doi:10.1016/0161-4630(78)90074-5)
34. Robison LM, Sylvester PW, Bikenfeld P, Lang JP & Bull RJ 1998 Comparison of the effects of iodine and iodide on thyroid function in humans. Journal of Toxicology and Environmental Health 55 93-106. (doi:10.1080/ 009841098158539)
35. Rosner H, Torremante P, Moller W & Gartner R 2010 Antiproliferative/cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGF-signaling, but evidence for apoptosis. Experimental and Clinical Endocrinology & Diabetes 118 410-419. (doi:10.1055/s-0029-1225615)
36. Russo J & Russo I 2000 Atlas and histological classification of tumors of the rat mammary gland. Journal of Mammary Gland Biology and Neoplasia 5 187-200. (doi:10.1023/A:1026443305758)
37. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A & Godbole MM 2006 Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. Journal of Biological Chemistry 281 19762-19771. (doi:10.1074/jbc.M600746200)
38. Sivaraman L & Medina D 2002 Hormone-induced protection against breast cancer. Journal of Mammary Gland Biology and Neoplasia 7 77-92. (doi:10.1023/A:1015774524076)
39. Tan WC, Privett OS & Goldyne ME 1974 Studies of prostaglandins in rat mammary tumors induced by 7,12-dymethyl-benz(a)anthracene. Cancer Research 34 3229-3231.
40. Thompson HJ 2000 Methods for the induction of mammary carcinogenesis in the rat using either 7,12-dimethylbenz[a]antracene or 1-methyl-1-nitro-sourea. In Methods in Mammary Gland Biology and Breast Cancer Research, pp 19-29. Eds MM Ip & BB Asch. New York, NY, USA: Kluwer Academic/Plenum Publishers.
41. Tikoo K, Kumar P & Gupta J 2009 Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA)-induced breast cancer rats. BMC Cancer 9 107-119. (doi:10.1186/1471-2407-9-107)
42. Venturi S, Donati FM, Venturi A, Venturi M, Grossi L & Guidi A 2000 Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Advances in Clinical Pathology 4 11-17.
43. Vitale M, Di Matola T, D'Ascoli F, Salzano S, Bogazzy F, Fenzi G, Martino E & Rossi G 2000 Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141 598-605. (doi:10.1210/en.141.2.598)
44. Wang T, Gavin HM, Arlt VM, Lawrence BP, Fenton SE, Medina D & Vorderstrasse BA 2011 Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors. International Journal of Cancer 128 1509-1523. (doi:10.1002/ijc.25493)
45. Zhang L, Sharma S, Zhu L, Kogai T, Hershman J, Brent G, Dubinett S & Huang M 2003 Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells. Cancer Research 63 5065-5072. (Pubitemid 37022646)